CA
NZ
UK
AU
IND
US
● No announcement, filing or analyst action explained the rise.
● Cue Biopharma soared on Friday, closing at $28.00 and ranking among theNasdaqComposite's biggest gainers.
● CVS Health came under pressure in early trading on Friday after the 2027MedicareAdvantage Star Ratings were released Thursday.
● No company announcement explained the rise.
● Its largest California contract slipped to 3.5 stars.
● Amgen rose on Friday, closing at $414.87 and finishing among the Dow's gainers, with no company-specific news.
● Arcturus jumped on Friday, trading at about $14.10 by mid-morning, as an analyst call met an mRNA rally.
● BioNTech rose firmly on Friday, trading at about $92.44 in the afternoon, with no new company announcement.
● Bolt Biotherapeutics climbed strongly on Friday, closing around $4.34, with no announcement from the company.
Alignment Healthcare (NASDAQ:ALHC) shares closed sharply lower after the company's 2027 Centers forMedicareand Medicaid Services Star Ratings showed its largest California contract falling to 3.5 stars from 4.0, threatening eligibility for 2028 quality bonus payments. Alignment Healthcare is a technology-driven, consumer-centric Medicare Advantage insurer …
Please wait processing your request...